loading page

Photobiomodulation treatment for head and neck atopic dermatitis resistant to Dupilumab: a case report.
  • +4
  • Giulia Tonini,
  • Giulia Davini,
  • Agata Janowska,
  • Michela Iannone,
  • Teresa Oranges,
  • Marco Romanelli,
  • Valentina Dini
Giulia Tonini
University of Pisa
Author Profile
Giulia Davini
University of Pisa
Author Profile
Agata Janowska
University of Pisa
Author Profile
Michela Iannone
University of Pisa
Author Profile
Teresa Oranges
University of Pisa
Author Profile
Marco Romanelli
University of Pisa
Author Profile
Valentina Dini
University of Pisa
Author Profile

Peer review status:UNDER REVIEW

02 Apr 2020Submitted to Clinical Case Reports
10 Apr 2020Assigned to Editor
10 Apr 2020Submission Checks Completed
22 Apr 2020Reviewer(s) Assigned
26 Apr 2020Review(s) Completed, Editorial Evaluation Pending

Abstract

We report the case of a man affected by atopic dermatitis on dupilumab. During the treatment, the patient showed a worsening of head and neck dermatitis. Blue light irradiation is a safe and efficacy tool for head and neck dermatitis persisting or developed during therapy with dupilumab.